Health Canada

Provides clinically relevant safety information on pharmaceuticals, biologics, medical devices and natural health products for health care professionals.

Provides clinically relevant safety information on pharmaceuticals, biologics, medical devices and natural health products for health care professionals.

This monthly publication is intended primarily for healthcare professionals and includes information on pharmaceuticals, biologics, medical devices and natural health products.

Provides clinically relevant safety information on pharmaceuticals, biologics, medical devices and natural health products for health care professionals.

This monthly publication is intended primarily for healthcare professionals and includes information on pharmaceuticals, biologics, medical devices and natural health products.

Provides clinically relevant safety information on pharmaceuticals, biologics, medical devices and natural health products for health care professionals.

Provides clinically relevant safety information on pharmaceuticals, biologics, medical devices and natural health products for health care professionals.

This guidance document applies to sponsors intending to make changes to new drugs that have received a NOC pursuant to Section C.08.004 of the Food and Drug Regulations. In the absence of a guidance specific to Quality changes to drugs which were approved through a Drug Identification Application...

The Health Product InfoWatch is a monthly publication intended primarily for healthcare professionals. It provides clinically relevant safety information on pharmaceuticals, biologics, medical devices and natural health products.

The Health Product InfoWatch is a monthly publication intended primarily for healthcare professionals. It provides clinically relevant safety information on pharmaceuticals, biologics, medical devices and natural health products.

The Health Product InfoWatch is a monthly publication intended primarily for healthcare professionals. It provides clinically relevant safety information on pharmaceuticals, biologics, medical devices and natural health products.

The Health Product InfoWatch is a monthly publication intended primarily for healthcare professionals. It provides clinically relevant safety information on pharmaceuticals, biologics, medical devices and natural health products.

The Health Product InfoWatch is a monthly publication intended primarily for healthcare professionals. It provides clinically relevant safety information on pharmaceuticals, biologics, medical devices and natural health products.

This guidance document applies to sponsors intending to make changes to new drugs that have received a NOC pursuant to section C.08.004 of the Food and Drug Regulations. These new drugs may include pharmaceuticals, biologics, and radiopharmaceuticals for human use and pharmaceutical and certain...

This guidance document applies to sponsors intending to make changes to new drugs that have received a NOC pursuant to Section C.08.004 of the Food and Drug Regulations. This may include pharmaceuticals, biologics and radiopharmaceuticals for human use and pharmaceutical, radiopharmaceutical and...

The medicine regulators from Australia, Canada, Singapore, Switzerland and the United Kingdom (Access Consortium) have discussed the regulatory evidence requirements for COVID-19 vaccine approvals and considerations for post-market pharmacovigilance. This collective statement on COVID-19 vaccines...